Results 181 to 190 of about 69,470 (266)

Screening Equine Skin and Mucous Membranes for Carriage of Coagulase‐Positive Staphylococci

Veterinary Dermatology, Volume 37, Issue 5, Page 681-687, October 2026.
ABSTRACT Background Commensal populations of coagulase‐positive Staphylococcus spp. (CoPS) in healthy horses are not well‐defined. Objective To determine the point prevalence, anatomical distribution, antimicrobial susceptibility and genomic characteristics of CoPS in healthy horses.
Christina M. Dierkes, Daniel O. Morris, Christine L. Cain, Laurel E. Redding, Maho Okumura, Alison Gore, Stephen D. Cole   +6 more
wiley   +1 more source

Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat <i>Pseudomonas aeruginosa</i> clinical isolates. [PDF]

JAC Antimicrob Resist
Mystakelis H, Shields RK, Mathers AJ, Bergman Y, Munita JM, Cosgrove SE, Simner PJ, Tamma PD.   +7 more
europepmc   +1 more source

Quantifying the effects of hemoglobin saturation on plasma strong ion difference during blood oxygenation and decarboxylation

Physiological Reports, Volume 14, Issue 19, October 2026.
Abstract The strong ion difference (SID) is assessed to interpret acid–base disorders, yet measured plasma values are influenced by electrolyte redistribution across compartments. Current models focus on pH‐dependent plasma‐erythrocyte shifts. Here, we aim to quantify the effects of hemoglobin oxygen saturation (sO2).
Lorenzo Giosa, Martin Krbec, Jakub Halamík, Adrian Bolnberger, Mattia Busana, Serena Brusatori, Tue Diemer, Søren R. Kristensen, Micah L. A. Heldeweg, Francesco Zadek, Stephen E. Rees, František Duška   +11 more
wiley   +1 more source

Cefiderocol nonsusceptibility among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i>: data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) program. [PDF]

Antimicrob Agents Chemother
Chiu P-W, Wang J-L, Hsueh S-C, Lee N-Y, Huang Y-T, Ko W-C, Hsueh P-R.   +6 more
europepmc   +1 more source

CLSI Guideline Supports Continual Improvement in the Laboratory [PDF]

Laboratory Medicine, 2011
openaire   +1 more source

Epidemiological Characteristics of Clinical <i>Aspergillus</i> Section <i>Nigri</i> and Mutations in <i>cyp51A</i> Gene. [PDF]

J Fungi (Basel)
Zhang Y, Zhang Y, Wang S, Zhou C, Pan J, Guo W, Hu B.   +6 more
europepmc   +1 more source

Methodological considerations for the establishment of epidemiological cutoff values for <i>Sporothrix</i> species using CLSI broth microdilution. [PDF]

Antimicrob Agents Chemother
Chen G, Zou Y, Chen K.
europepmc   +1 more source

Genetic characterization of carbapenem-resistant <i>Klebsiella pneumoniae</i> bloodstream isolates with reduced susceptibility to cefiderocol. [PDF]

Front Cell Infect Microbiol
Wang M, Wu X, Yuan N, Li L, Zhang Z.
europepmc   +1 more source

<i>In vitro</i> potency of novel ertapenem/zidebactam combination (WCK 6777) against carbapenemase-producing Enterobacterales collected across India. [PDF]

JAC Antimicrob Resist
Bakthavatchalam YD, Bonomo R, Egli A, Puthan R, Shankar A, Krishnamoorthy S, Nagvekar V, Ekadashi RS, J S, Rajan S, Rodrigues C, Jayaprada R, Manesh A, Veeraraghavan B.   +13 more
europepmc   +1 more source

A mobile based antimicrobial susceptibility testing device - prototype development and validation. [PDF]

Indian J Med Res
Aravindh A, Gupta A, Sen M, Das A, Agarwal J.   +4 more
europepmc   +1 more source